BioSpace News Archive

Immunovia AB (publ) (“Immunovia”) today published two new data sets in scientific poster formats, including results from the development phase of the Company’s IMMray™ PanCan-d blood based test for early detection of pancreatic cancer.

RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of an independent, third-party test that indicates the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.9% of the SARS-CoV-2 virus in the air and on inoculated surfaces.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company , today announced it has expanded its licensing agreement from North Carolina State University (" NC State ") to include the worldwide development and commercialization of treatments targeting mast cell derived cancers and anaphylaxis.

The Government of Canada is taking steps to ensure more people in Canada are vaccinated more quickly, and continues to work to give Canadians access to safe and effective COVID-19 vaccines as soon as possible

Today, the U.S. Food and Drug Administration authorized marketing of a new device intended to be worn around the neck of athletes aged 13 years and older during sports activities to aid in the protection of the brain from the effects associated with repetitive sub-concussive head impacts.

MatMaCorp (Materials and Machines Corporation), a developer of comprehensive molecular diagnostic systems, today announced data demonstrating the effectiveness of the company’s COVID-19 2SF RNA test in detecting variants associated with SARS-CoV-2, the virus causing COVID-19.

The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts.

Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin and former Google AI/ML industry veteran Bradford Cross added to MindMed executive team

Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences

NANOBIOTIX (Euronext : NANO – NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced its revenues for the fourth quarter and full year ended December 31, 2020.